SNY vs. REGN
Compare and contrast key facts about Sanofi (SNY) and Regeneron Pharmaceuticals, Inc. (REGN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNY or REGN.
Correlation
The correlation between SNY and REGN is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SNY vs. REGN - Performance Comparison
Key characteristics
SNY:
0.84
REGN:
-1.18
SNY:
1.42
REGN:
-1.58
SNY:
1.16
REGN:
0.80
SNY:
0.89
REGN:
-0.63
SNY:
2.22
REGN:
-1.30
SNY:
8.63%
REGN:
21.89%
SNY:
22.68%
REGN:
23.98%
SNY:
-46.65%
REGN:
-91.81%
SNY:
-6.89%
REGN:
-43.95%
Fundamentals
SNY:
$137.26B
REGN:
$73.71B
SNY:
$2.28
REGN:
$38.33
SNY:
23.90
REGN:
17.57
SNY:
1.17
REGN:
0.99
SNY:
$36.66B
REGN:
$14.20B
SNY:
$25.74B
REGN:
$12.00B
SNY:
$9.62B
REGN:
$4.81B
Returns By Period
In the year-to-date period, SNY achieves a 13.00% return, which is significantly higher than REGN's -5.44% return. Over the past 10 years, SNY has underperformed REGN with an annualized return of 4.42%, while REGN has yielded a comparatively higher 4.76% annualized return.
SNY
13.00%
7.41%
-0.04%
18.02%
4.57%
4.42%
REGN
-5.44%
-1.17%
-43.72%
-28.95%
10.99%
4.76%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNY vs. REGN — Risk-Adjusted Performance Rank
SNY
REGN
SNY vs. REGN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Regeneron Pharmaceuticals, Inc. (REGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SNY vs. REGN - Dividend Comparison
SNY's dividend yield for the trailing twelve months is around 3.74%, while REGN has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNY Sanofi | 3.74% | 4.22% | 3.83% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.79% | 4.19% |
REGN Regeneron Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
SNY vs. REGN - Drawdown Comparison
The maximum SNY drawdown since its inception was -46.65%, smaller than the maximum REGN drawdown of -91.81%. Use the drawdown chart below to compare losses from any high point for SNY and REGN. For additional features, visit the drawdowns tool.
Volatility
SNY vs. REGN - Volatility Comparison
The current volatility for Sanofi (SNY) is 6.36%, while Regeneron Pharmaceuticals, Inc. (REGN) has a volatility of 9.06%. This indicates that SNY experiences smaller price fluctuations and is considered to be less risky than REGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SNY vs. REGN - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Regeneron Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities